a drug that is used to treat certain skin conditions and is being studied in the treatment of cutaneous (skin-related) t-cell cancer and t-cell non-hodgkin lymphoma. alefacept is made by combining part of an antibody with a protein that blocks the growth some types of t cells. it is a type of fusion protein and a type of immunosuppressant. also called amevive.